Cigna Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cigna Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,860	Closed	-$242K	–	682
2021 Q3	$242K	Hold	1,860	–	–	0.02%	639
2021 Q2	$330K	Sell	1,860 -183	-9%	-$31.7K	0.02%	539
2021 Q1	$336K	Buy	2,043 +109	+6%	+$17.9K	0.02%	563
2020 Q4	$319K	Buy	1,934 +227	+13%	+$33.8K	0.02%	533
2020 Q3	$244K	Sell	1,707 -720	-30%	-$89.3K	0.02%	536
2020 Q2	$268K	Sell	2,427 -1,054	-30%	-$117K	0.03%	583
2020 Q1	$347K	Sell	3,481 -5,799	-62%	-$750K	0.04%	412
2019 Q4	$1.33M	Sell	9,280 -85	-0.9%	-$11.6K	0.14%	187
2019 Q3	$1.18M	Hold	9,365	–	–	0.12%	219
2019 Q2	$1.3M	Hold	9,365	–	–	0.14%	185
2019 Q1	$1.34M	Buy	+9,365	New	+$1.22M	0.15%	162

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cigna Investments's JAZZ Position: Q4 2021 in Review

Cigna Investments sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2021, closing a stake of 1,860 shares — an estimated $242K sold.

Cigna Investments first reported a position in JAZZ in Q1 2019 and held it in 11 quarters. The position peaked at $1.34M in Q1 2019. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

Cigna Investments reported no remaining Jazz Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Cigna Investments sold 1,860 Jazz Pharmaceuticals shares in Q4 2021, an estimated $242K.
Cigna Investments first reported a position in Jazz Pharmaceuticals in Q1 2019 and held it in 11 quarters.
Cigna Investments's Jazz Pharmaceuticals position peaked at $1.34M in Q1 2019.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Cigna Investments's 13F filing for Q4 2021, filed 14 Feb 2022.